Patent details
LUC50045 Product Name: ROMVIMZA - vimseltinib
Basic Information
- Publication number:
- LUC50045
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP147640320
- Legal Status:
- Pending & Published
- Application number:
- LUC50045
- First applicant's nationality:
- Procedural language:
- English
Marketing Authorization
- Marketing Authorization Number:
- EU/1/25/1968
- Marketing Authorization Type:
- Marketing Authorization Date:
- 24/09/2025
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 09/03/2026
- First Marketing Authorization date:
- 24/09/2025
- Grant date:
- Activation date:
- Publication date:
- 09/03/2026
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 14/03/2039
- SPC Extension Expiration:
- 14/03/2039
- Rejection date:
- Withdrawal date:
Owner
- From:
- 09/03/2026
- Name:
- Deciphera Pharmaceuticals, LLC
- Address:
- 643 Massachusetts, Suite 200, Lawrence, Kansas 66044, United States (US)
Agent
- Name:
- Patent42 SA
- From:
- 09/03/2026
- Address:
- 5, rue Dicks, 4081, Esch-sur-Alzette, Luxembourg (LU)
- To:
| Filing date | Document type | Number of pages |
|---|---|---|
| 09/03/2026 | Application Form | 5 |
| 09/03/2026 | General Document | 1 |
| 09/03/2026 | General Document | 3 |
| 09/03/2026 | General Document | 1 |
| 09/03/2026 | General Document | 46 |
| 09/03/2026 | Outgoing Correspondence | 2 |
| 09/03/2026 | Outgoing Correspondence | 1 |